Virtual Incision’s MIRA Surgical Robot to Show Skills on International Space Station

A NASA grant enabled Virtual Incision to prepare MIRA for simulated surgical operations in orbit.

Virtual Incision

Virtual Incision has designed the MIRA surgical assistive robot to be portable. It will be tested on the International Space Station.
Virtual Incision said its MIRA miniaturized robot-assisted surgical device will demonstrate the potential for greater access to surgical care on Earth and beyond.

In space, robots could someday make housecalls for doctors far from astronauts. Virtual Incision Corp. last week announced that it will test its MIRA surgical robot's skills in a 2024 technology demonstration mission aboard the International Space Station, or ISS.

“The Virtual Incision MIRA platform was designed to deliver the power of a mainframe robotic-assisted surgery [RAS] device in a miniaturized size, with the goal of making RAS accessible in any operating room on the planet,” stated John Murphy, CEO of Virtual Incision. “Working with NASA aboard the space station will test how MIRA can make surgery accessible in even the most faraway places.”

Virtual Incision said it holds more than 200 patents and patent applications. It raised $43 million in Series C funding in November 2021. The Lincoln, Neb.-based company claimed that MIRA is the first RAS platform of its kind. 

Virtual Incision designs for portability, fast setup

MIRA's small design could offer the benefits of RAS during abdominal procedures without the logistical inefficiencies of traditional mainframe systems, said Virtual Incision. The device weighs about 2 lb. and avoids the need for a dedicated mainframe room, the company added.

With its drape- and dock-free design and portability, MIRA is quick to set up, clean, and move in between cases, according to Virtual Incision. The company said the system could allow healthcare providers to increase their robotic-assisted surgery caseload.

MIRA is currently in U.S. Food and Drug Administration (FDA) clinical trials under an investigational device exemption (IDE) and is not yet available for sale. MIRA is currently in the final stages of its U.S. clinical trial.

“I’ve been excited about the ongoing trial thus far because we have confirmed many of the design attributes of MIRA,” said Shane Farritor, co-founder and chief technology officer at Virtual Incision. “For example, the device really can be set up in many different operating rooms.”

“Also, the device can be easily and quickly moved to various quadrants inside the abdominal cavity. Many of these attributes have been highlighted in our trial,” he told Robotics 24/7. “Our hope is to submit to the FDA [for final approval] around the end of 2022.”

NASA to conduct surgical trials in space

The National Aeronautics and Space Administration (NASA) recently awarded the grant to the University of Nebraska-Lincoln through the Established Program to Stimulate Competitive Research (EPSCoR) at the University of Nebraska Omaha.

Virtual Incision said MIRA's small size makes it appealing to surgeons and hospital staffers. The design is also suitable for use within the tight space and mass requirements of a long-duration space mission, said the company.

To prepare MIRA for use in space, the robot will need to be secured for launch, include self-contained sessions, and get approval from various stakeholders, acknowledged Farritor.

“MIRA is being well-tested for use in terrestrial applications,” he told Robotics 24/7. “A lot of effort has gone into building a reliable and robust device.”

“However, there will be a lot of new challenges for using MIRA in zero gravity,” Farritor said. “Nothing about space flight is easy, and I’d hate to pick a 'biggest.'”

Virtual Incision MIRA robot-assisted surgical system

Virtual Incision claimed that MIRA is the world’s first miniaturized robotic-assisted surgery (RAS) platform. Source: Business Wire

MIRA to simulate surgical tasks on ISS

Once aboard the ISS, MIRA will operate inside a microwave-oven-sized experiment locker and perform activities that simulate those used in surgery, such as cutting simulated tissue and manipulating small objects. The robot will act with a minimum of input from the crew, noted Farritor.

“This will simply be a technology demonstration,” he said. “The astronaut will flip a switch, and MIRA will then operate simulated surgical tasks on its own. This is different from how MIRA works on earth, where a surgeon is the one facilitating the movement.”

“NASA has ambitious plans for long-duration space travel, and it’s important to test the capabilities of technology that may be beneficial during missions measured in months and years,” said Farritor. “MIRA continues to push the boundaries of what’s possible in RAS, and we are pleased with its performance so far during clinical trials.”

“We’re excited to take it a step further and help identify what could be possible in the future as space travel is becoming more of a reality for mankind,” he said. The ISS has hosted a variety of robots, including robotic arms, floating assistive systems, and humanoid models.

Robots could enable surgery near and far

In addition, MIRA has potential for field use here on Earth, said Farritor. “We believe the small size of MIRA simplifies its use on Earth because it is portable and easy to set up,” he noted. “Use on the ISS will dramatically demonstrate MIRA’s portability and that it really can be used anywhere, any time.”

“Our research inside the University of Nebraska has had long-standing sponsorship from both the [U.S.] Army and NASA because both want to do surgery in forward and far-off environments,” Farritor said. “In the long-term, we think telemedicine is a real possibility for this technology.”

“MIRA’s portability and small size means it can easily be transported,” he said. “[This] is a key differentiator of MIRA, as other RAS platforms require a dedicated OR with scheduling limitations.

Farritor serves as professor of engineering at the University of Nebraska-Lincoln, where he has led research on the potential use of surgical robots in space. Prior to Virtual Incision, Farritor studied at the Kennedy Space Center, Goddard Space Flight Center, and the Jet Propulsion Laboratory.

He co-founded Virtual Incision with Dmitry Oleynikov, MD. They have combined their experience in engineering and minimally invasive surgery to help create MIRA.

MIRA ("miniaturized in vivo robotic assistant") is an investigational robot that will enable surgeons to perform minimally invasive surgeries in any hospital or surgery center, without the need for a dedicated space or for the infrastructure typically required for other "mainframe” robotic systems.

About the Author

Eugene Demaitre's avatar
Eugene Demaitre
Eugene Demaitre was editorial director of Robotics 24/7. Prior to joining Peerless Media, he was a senior editor at Robotics Business Review and The Robot Report. Demaitre has also worked for BNA (now part of Bloomberg), Computerworld, and TechTarget. He has participated in numerous robotics-related webinars, podcasts, and events worldwide.
Follow Eugene:    
Follow Robotics 24/7 on Facebook
Follow Robotics 24/7 on Linkedin

Email Sign Up

Get news, papers, media and research delivered
Stay up-to-date with news and resources you need to do your job. Research industry trends, compare companies and get market intelligence every week with Robotics 24/7. Subscribe to our robotics user email newsletter and we'll keep you informed and up-to-date.

Virtual Incision

Virtual Incision has designed the MIRA surgical assistive robot to be portable. It will be tested on the International Space Station.

Robot Technologies